StockStory.org on MSN16d
Clover Health (NASDAQ:CLOV) Reports Sales Below Analyst Estimates In Q4 EarningsHealth insurance company Clover Health (NASDAQ:CLOV) in Q4 CY2024, with sales falling 34% year on year to $337 million. Its GAAP loss of $0.04 per share was $0.03 above analysts’ consensus estimates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results